Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 11, 2013, Pages

  Rickels, Michael R ^a   Kong, Stephanie M ^a   Fuller, Carissa ^a   Dalton Bakes, Cornelia ^a   Ferguson, Jane F ^a   Reilly, Muredach P ^a   Teff, Karen L ^a   Naji, Ali ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GRAFT RECIPIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; LIVER LEVEL; LOW DRUG DOSE; MALE; METABOLIC REGULATION; OUTCOME ASSESSMENT; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SKELETAL MUSCLE; TREATMENT RESPONSE;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE CLAMP TECHNIQUE; GRAFT REJECTION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; SIROLIMUS; TACROLIMUS;

EID: 84887434403     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1764     Document Type: Article

References (21)

1. Defronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes. 1982;31: 795-801.
2. Zunigaguajardo S, Zinman B. The metabolic response to the eugylcemic insulin clamp in type I diabetes and normal humans. Metab Clin Exp. 1985;34: 926-930.
3. Ykijarvinen H, Helve E, Koivisto VA. Hyperglycemia decreases glucose- uptake in type I diabetes. Diabetes. 1987;36: 892-896.
4. Rickels MR, Naji A, Teff KL. Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. J Clin Endocrinol Metab. 2006;91: 2138-2144.
5. Hirsch D, Odorico J, Radke N, et al. Correction of insulin sensitivity and glucose disposal after pancreatic islet transplantation: preliminary results. Diabetes Obes Metab. 2010;12: 994-1003.
6. Vethakkan SR, Walters JM, Goodman DJ, et al. Normalized NEFA dynamics during an OGTT after islet transplantation. Transplantation. 2012;94:e49-e51.
7. Lopez-Talavera JC, Garcia-Ocana A, Sipula I, Takane KK, Cozar- Castellano I, Stewart AF. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology. 2004;145: 467-474.
8. Larsen JL, Bennett RG, Burkman T, et al. Tacrolimus and sirolimus cause insulin resistance in normal Sprague Dawley rats. Transplantation. 2006;82: 466-470.
9. Clinical Islet Transplantation Trial web site. http://www.isletstudy- .org/. Accessed May 1, 2012.
10. Rickels MR, Schutta MH, Mueller R, et al. Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients. J Clin Endocrinol Metab. 2007;92: 873-879.
11. Bernroider E, Brehm A, KrssakM,et al. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes. J Clin Endocrinol Metab. 2005;90: 5559-5565.
12. Kacerovsky M, Jones J, Kacerovsky-Bielesz G, et al. Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes. Diabetes. 2011;60: 1752-1758.
13. Wolfe RR, Chinkes DL. Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis. Hoboken, NJ: John Wiley, Sons, Inc; 2005.
14. Matsuda M, Defronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22: 1462-1470.
15. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 1987;79: 790-800.
16. Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev. 2002;18: 192-200.
17. Bergman BC, Howard D, Schauer IE, et al. Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. J Clin Endocrinol Metab. 2012;97: 1663-1672.
18. Trevisan R, Nosadini R, Avogaro A, et al. Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino-acid-metabolism. J Clin Endocrinol Metab. 1986;62: 1155-1162.
19. Kneteman NM, Lakey JR, Wagner T, Finegood D. The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. Transplantation. 1996;61: 1206-1210.
20. Soleimanpour SA, Hirshberg B, Bunnell DJ, et al. Metabolic function of a suboptimal transplanted islet mass in nonhuman primates on rapamycin monotherapy. Cell Transplantation. 2012;21:1297- 1304.
21. Krebs M, Brunmair B, Brehm A, et al. The mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes. 2007;56: 1600-1607.